ALXN
Alexion Pharmaceuticals Inc
ALXN
ALXN
Delisted
ALXN was delisted on the 20th of July, 2021.
650 hedge funds and large institutions have $18B invested in Alexion Pharmaceuticals Inc in 2020 Q1 according to their latest regulatory filings, with 84 funds opening new positions, 266 increasing their positions, 230 reducing their positions, and 92 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
650
Holders Change
-15
Holders Change %
-2.26%
% of All Funds
14.36%
Holding in Top 10
19
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+18.75%
% of All Funds
0.42%
New
84
Increased
266
Reduced
230
Closed
92
Calls
$279M
Puts
$367M
Net Calls
-$87.9M
Net Calls Change
+$91.8M
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
$258M |
| 2 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
$148M |
| 3 |
DnB Asset Management
Oslo,
Norway
|
$69.7M |
| 4 |
Millennium Management
New York
|
$70.4M |
| 5 |
TCM
TimesSquare Capital Management
New York
|
$56.2M |
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
$767M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
$1.07B |
| 3 |
Artisan Partners
Milwaukee,
Wisconsin
|
$95.7M |
| 4 |
JPMorgan Chase & Co
New York
|
$265M |
| 5 |
Goldman Sachs
New York
|
$119M |
